OverviewSuggest Edit

Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left and right carotid arteries. The company also offers Rheos programmer system that communicates with the Rheos pulse generator. CVRx, Inc. was founded in 2001 and is based in Minneapolis, Minnesota.
TypePrivate
Founded2001
HQMinneapolis, US
Websitecvrx.com

Latest Updates

Employees (est.) (May 2020)64

Key People/Management at CVRx

Ali Behbahni

Ali Behbahni

New Enterprise Associates
Kadir Kadhiresan

Kadir Kadhiresan

Johnson & Johnson Development Corporation
John M. Nehra

John M. Nehra

Special Partner of NEA
Tom Heyman

Tom Heyman

Johnson & Johnson Development Corporation
Geoff Pardo

Geoff Pardo

Gilde
Joseph Slattery

Joseph Slattery

TransEnterix, Exosome Diagnostics, Replimune
Show more

CVRx Office Locations

CVRx has an office in Minneapolis
Minneapolis, US (HQ)
9201 W Broadway Ave #650
Show all (1)

CVRx Financials and Metrics

Summary Metrics

Founding Date

2001

CVRx total Funding

$305.6 m

CVRx latest funding size

$12 m

Time since last funding

3 years ago

CVRx investors

CVRx's latest funding round in June 2017 was reported to be $12 m. In total, CVRx has raised $305.6 m
Show all financial metrics

CVRx Online and Social Media Presence

Embed Graph

CVRx News and Updates

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

MINNEAPOLIS, Aug. 16, 2019 /PRNewswire/ -- CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug Administration (FDA) to market its BAROSTIM NEO device for heart failure in the United States. The...

CVRx Blogs

See the 6 month data from the BeAT Heart Failure Study presented on 9 May 2019 at HRS in the Late Breaking Clinical Trials Session.

The post See the 6 month data from the BeAT Heart Failure Study presented on 9 May 2019 at HRS in the Late Breaking Clinical Trials Session. appeared first on CVRx INC..

The 6 month data from the BeAT Heart Failure Study is scheduled to be presented at 8:54AM on 9 May 2019 at HRS in the Session 1 of the Late Breaking Clinical Trials.

Session 1 of the Late Breaking Clinical Trials. The post The 6 month data from the BeAT Heart Failure Study is scheduled to be presented at 8:54AM on 9 May 2019 at HRS in the Session 1 of the Late Breaking Clinical Trials. appeared first on CVRx INC..
Show more

CVRx Frequently Asked Questions

  • When was CVRx founded?

    CVRx was founded in 2001.

  • Who are CVRx key executives?

    CVRx's key executives are Ali Behbahni, Kadir Kadhiresan and John M. Nehra.

  • How many employees does CVRx have?

    CVRx has 64 employees.

  • Who are CVRx competitors?

    Competitors of CVRx include Purigen Biosystems, AxoGen and Synchron.

  • Where is CVRx headquarters?

    CVRx headquarters is located at 9201 W Broadway Ave #650, Minneapolis.

  • Where are CVRx offices?

    CVRx has an office in Minneapolis.

  • How many offices does CVRx have?

    CVRx has 1 office.